Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany. (Q50578983)
Jump to navigation
Jump to search
scientific article published in June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany. |
scientific article published in June 2005 |
Statements
Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon alpha-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany. (English)
1 reference
1 reference
Ulrike Ravens-Sieberer
1 reference
Monika Bullinger
1 reference
Bärbel M Kurth
1 reference
Uwe Siebert
1 reference
Gaby Sroczynski
1 reference
Wolfgang Greiner
1 reference
Pamela Aidelsburger
1 reference
J-Matthias Graf von der Schulenburg
1 reference
John B Wong
1 reference
Siegbert Rossol
1 reference
1 June 2005
1 reference
6
1 reference
2
1 reference
112-123
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference